Skip to main content
Media Coverage

U.S. approval for psychedelic drug MDMA nears after success in clinic [Labiotech]

By September 22, 2023No Comments

The psychedelic drug MDMA edges closer towards FDA approval for the treatment of post-traumatic stress disorder (PTSD) in the U.S., after promising results of a trial were published. This comes after Australia became the first country to allow doctors to prescribe the drug to those struggling with mental health disorders like PTSD and depression.

Full Story